Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tolerizing DNA vaccines for autoimmune arthritis.

Peggy P Ho1, John P Higgins, Brian A Kidd

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.

Autoimmunity
|December 21, 2006
PubMed
Summary

New antigen-specific tolerizing DNA vaccines effectively treat collagen-induced arthritis (CIA) in mice. This approach, enhanced by atorvastatin, shows promise for autoimmune disease therapies by reducing pro-inflammatory cytokines and autoantibody responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis.

Frontiers in immunology·2026
Same author

C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma Proteomics.

Cellular and molecular neurobiology·2026
Same author

Peripheral complement C4 protein in schizophrenia: Association with gene copy number and immune cell subtypes.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Why Is MS a More Frequent Complication of EBV Infection in Females?

Immunological reviews·2026
Same author

Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders.

ImmunoTargets and therapy·2026

Area of Science:

  • Immunology
  • Vaccinology
  • Autoimmune Diseases

Background:

  • Current rheumatoid arthritis (RA) therapies non-specifically suppress immunity, highlighting the need for antigen-specific tolerizing treatments.
  • Developing targeted therapies is crucial for managing autoimmune diseases effectively.

Purpose of the Study:

  • To develop and evaluate antigen-specific tolerizing DNA vaccines for treating collagen-induced arthritis (CIA) in a mouse model.
  • To utilize protein microarrays for monitoring therapeutic responses and identifying new autoimmune targets.

Main Methods:

  • Developed tolerizing DNA vaccines encoding type II collagen (CII).
  • Administered vaccines to mice with CIA, with some receiving atorvastatin.
  • Analyzed cytokine production (IFN-gamma, TNF-alpha) from T cells.

Related Experiment Videos

  • Used arthritis microarray analysis to assess autoantibody responses.

    • Main Results:

    • Tolerizing DNA vaccines encoding CII significantly reduced CIA incidence and severity.
    • Atorvastatin potentiated the therapeutic effect of the CII DNA vaccines.
    • Vaccine treatment led to reduced production of pro-inflammatory cytokines IFN-gamma and TNF-alpha.
    • Microarray analysis showed decreased autoantibody spreading in treated mice.

    Conclusions:

    • Antigen-specific tolerizing DNA vaccines are a promising strategy for treating CIA and potentially other autoimmune diseases like RA.
    • Antibody profiling is valuable for guiding the design and monitoring of these novel vaccine therapies.